Gcgr-KO(2)

Nomenclature

C57BL/6JSmo-Gcgrem2Smoc

Cat. NO.

NM-KO-210289

Strain State

Embryo Cryopreservation

Export PDF

Gene Summary

Gene Symbol
Gcgr

Model Description

Gcgr-KO(2) mice (Stock No.NM-KO-210289)carry a knockout allele derived from the targeted deletion of exon 4-10. While Gcgr-KO mice (Stock No.NM-KO-200217)mice carrying the exon 4-9 deletion.

Validation Data

image.png

Fig.1 Detection of Gcgr expression in liver by RT-PCR. Mouse Gapdh mRNA (123 bp) was detectable both in wild-type C57BL/6 mice and homozygous Gcgr-KO(2) mice. Mouse Gcgr mRNA (166 bp) was detectable only in wild-type mice but not in homozygous Gcgr-KO(2) mice. Liver RNA was extracted from 8-week-old male and female wild-type C57BL/6 (WT) (n=2) and homozygous Gcgr-KO(2) mice (HO) (n=2), then cDNA libraries were synthesized by reverse transcription, followed by PCR with mRNA primers. 

Abbr. M, marker; HO, homozygous; WT, wild type.

image.png

Fig.2 Detection of Gcgr expression in liver by qPCR. Mouse Gcgr mRNA was detectable only in wild-type mice but not in homozygous Gcgr-KO(2) mice. Liver RNA were extracted from 8-week-old male and female wild-type C57BL/6 (WT) (n=2) and homozygous Gcgr-KO(2) mice (HO) (n=2), then cDNA libraries were synthesized by reverse transcription, followed by qPCR with mouse Gcgr and mouse Gapdh primers. Relative expression represents the mouse Gcgr mRNA level relative to its average expression in wild-type mice. 

Abbr. M, marker; HO, homozygous; WT, wild type.

image.png

Fig.3 Body weight and tissues weight of WT C57BL/6 mice and Gcgr-KO(2) mice without fasting. Gcgr-KO(2) mice exhibited significant decreases in liver weight and kidney weight compared to WT C57BL/6 mice.

Abbr. HO, homozygous; WT, wild type; eWAT, epididymal white adipose tissue; sWAT, subcutaneous white adipose tissue.

image.png

Fig.4 Detection of glucagon levels in plasma of WT C57BL/6 mice and HO Gcgr-KO(2) mice by ELISA. In contrast to the low baseline glucagon in WT C57BL/6 mice, Gcgr-KO(2) mice developed severe compensatory hyperglucagonemia resulting from defective negative feedback. Plasma was collected from wild-type C57BL/6 mice (n=5, male, 18 weeks old) and HO Gcgr-KO(2) mice (n=4, male, 18 weeks old) without fasting, and analyzed by ELISA.

Abbr.  HO, homozygous; WT, wild type; N.D. not detected.

image.png

Fig.5 Detection of TG levels in liver of WT C57BL/6 mice and HO Gcgr-KO(2) mice by ELISA. Gcgr-KO(2) mice exhibited an obvious decrease in hepatic TG levels relative to WT C57BL/6 mice, possibly reflecting a decreased hepatic TG uptake in the Gcgr-KO mice. Liver homogenates were collected from wild-type C57BL/6 mice (n=5, male, 18 weeks old) and HO Gcgr-KO(2) mice (n=4, male, 18 weeks old) without fasting, and analyzed by ELISA.

Abbr.  HO, homozygous; WT, wild type.

image.png

Fig.6 Blood biochemical test of WT C57BL/6 mice and HO Gcgr-KO(2) mice. Gcgr-KO(2) mice exhibited significant lower ALT and AST levels and higher TG, LDL-C and NEFA levels compared to WT mice. Serum was collected from wild-type C57BL/6 mice (n=5, male, 18 weeks old) and HO Gcgr-KO(2) mice (n=4, male, 18 weeks old) without fasting to detecte blood biochemical profiles. 

Abbr.  HO, homozygous; WT, wild type.


You may also like

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

Learn more

Workshop:Progress and Advances in Preclinical immuno-Oncology Research

SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.

Learn more

Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!

At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.

Learn more